KOSPI · Healthcare · ₩309B
₩5,030-0.59%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
12/'25 vs prev quarter
Short Volume 0.3% · as of 26.10.27
Among 37 신약 개발 peers
Quarterly Revenue Growth
“허가받은 제품이 매출로 이어지며 다음 성장을 준비해요.”
In the company's words · 2026 4분기 filing